Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis

Human Molecular Genetics

Volumn 22, Issue 12, 2013, Pages 2350-2360

  Kabashi, Edor ^a,b   El Oussini, Hajer ^c,d   Bercier, Valérie ^a   Gros Louis, François ^b   Valdmanis, Paul N ^b   Mcdearmid, Jonathan ^e   Mejier, Inge A ^b   Dion, Patrick A ^b,f   Dupre, Nicolas ^g   Hollinger, David ^c,d   Sinniger, Jérome ^c,d   Dirrig Grosch, Sylvie ^c,d   Camu, William ^h   Meininger, Vincent ^i,j   Loeffler, Jean Philippe ^c,d   René, Frédérique ^c,d   Drapeau, Pierre ^f   Rouleau, Guy A ^b,f   Dupuis, Luc ^c,d  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b UNIVERSITY OF MONTREAL   (Canada)

^c INSERM   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALS8 GENE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; LOSS OF FUNCTION MUTATION; MOTONEURON; MOUSE; NERVE DEGENERATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VESICLE ASSOCIATED MEMBRANE PROTEIN ASSOCIATED PROTEIN B GENE; ZEBRA FISH;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BASE SEQUENCE; COHORT STUDIES; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ALIGNMENT; VESICULAR TRANSPORT PROTEINS; ZEBRAFISH;

ANIMALIA; DANIO RERIO; MUS; VERTEBRATA;

EID: 84878487878     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt080     Document Type: Article

References (44)

1. Kiernan, M.C., Vucic, S., Cheah, B.C., Turner, M.R., Eisen, A., Hardiman, O., Burrell, J.R. and Zoing, M.C. (2011) Amyotrophic lateral sclerosis. Lancet, 377, 942-955.
2. Wijesekera, L.C. and Leigh, P.N. (2009) Amyotrophic lateral sclerosis. Orphanet J. Rare Dis., 4, 3.
3. Gros-Louis, F., Gaspar, C. and Rouleau, G.A. (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta, 1762, 956-972.
4. Nishimura, A.L., Mitne-Neto, M., Silva, H.C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J.R., Gillingwater, T., Webb, J. et al. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet., 75, 822-831.
5. Chen, H.J., Anagnostou, G., Chai, A., Withers, J., Morris, A., Adhikaree, J., Pennetta, G. and de Belleroche, J.S. (2010) Characterisation of the properties of a novel mutation in VAPB in familial ALS. J. Biol. Chem., 285, 40266-40281.
6. Rocha, N., Kuijl, C., van der Kant, R., Janssen, L., Houben, D., Janssen, H., Zwart, W. and Neefjes, J. (2009) Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning. J. Cell Biol., 185, 1209-1225.
7. Gkogkas, C., Middleton, S., Kremer, A.M., Wardrope, C., Hannah, M., Gillingwater, T.H. and Skehel, P. (2008) VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet., 17, 1517-1526.
8. Kanekura, K., Nishimoto, I., Aiso, S. and Matsuoka, M. (2006) Characterization of amyotrophic lateral sclerosis-linked pro56ser mutation of vesicle-associated membrane protein-associated protein B (VAPB/ ALS8). J. Biol. Chem., 281, 30223-30233.
9. Suzuki, H., Kanekura, K., Levine, T.P., Kohno, K., Olkkonen, V.M., Aiso, S. and Matsuoka, M. (2009) ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem., 108, 973-985.
10. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M.O., Akhmanova, A., Jaarsma, D. and Hoogenraad, C.C. (2007) Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci., 27, 9801-9815.
11. Qiu, L., Qiao, T., Beers, M., Tan, W., Wang, H., Yang, B. and Xu, Z. (2013) Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Mol. Neurodegener., 8, 1.
12. Tudor, E.L., Galtrey, C.M., Perkinton, M.S., Lau, K.F., De Vos, K.J., Mitchell, J.C., Ackerley, S., Hortobagyi, T., Vamos, E., Leigh, P.N. et al. (2010) Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience, 167, 774-785.
13. Mitne-Neto, M., Machado-Costa, M., Marchetto, M.C., Bengtson, M.H., Joazeiro, C.A., Tsuda, H., Bellen, H.J., Silva, H.C., Oliveira, A.S., Lazar, M. et al. (2011) Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet., 20, 3642-3652.
14. Anagnostou, G., Akbar, M.T., Paul, P., Angelinetta, C., Steiner, T.J. and de Belleroche, J. (2010) Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging, 31, 969-985.
15. Landers, J.E., Leclerc, A.L., Shi, L., Virkud, A., Cho, T., Maxwell, M.M., Henry, A.F., Polak, M., Glass, J.D., Kwiatkowski, T.J. et al. (2008) New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology, 70, 1179-1185.
16. Vaccaro, A., Patten, S.A., Ciura, S., Maios, C., Therrien, M., Drapeau, P., Kabashi, E. and Parker, J.A. (2012) Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. Elegans and D. Rerio. PLoS One, 7, e42117.
17. Langou, K., Moumen, A., Pellegrino, C., Aebischer, J., Medina, I., Aebischer, P. and Raoul, C. (2010) AAV-mediated expression of wild-type and ALS-linked mutant VAPB selectively triggers death of motoneurons through a Ca2+-dependent ER-associated pathway. J. Neurochem., 114, 795-809.
18. Saxena, S., Cabuy, E. and Caroni, P. (2009) A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci., 12, 627-636.
19. Kikuchi, H., Almer, G., Yamashita, S., Guegan, C., Nagai, M., Xu, Z., Sosunov, A.A., McKhann, G.M. 2nd and Przedborski, S. (2006) Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl Acad. Sci. USA, 103, 6025-6030.
20. Wu, J., Rutkowski, D.T., Dubois, M., Swathirajan, J., Saunders, T., Wang, J., Song, B., Yau, G.D. and Kaufman, R.J. (2007) ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell, 13, 351-364.
21. van Blitterswijk, M., van Es, M.A., Koppers, M., van Rheenen, W., Medic, J., Schelhaas, H.J., van der Kooi, A.J., de Visser, M., Veldink, J.H. and van den Berg, L.H. (2012) VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiol. Aging, 33, 2950.
22. Nishimura, A.L., Al-Chalabi, A. and Zatz, M. (2005) A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum. Genet., 118, 499-500.
23. Tomiyama, H., Kokubo, Y., Sasaki, R., Li, Y., Imamichi, Y., Funayama, M., Mizuno, Y., Hattori, N. and Kuzuhara, S. (2008) Mutation analyses in amyotrophic lateral sclerosis/parkinsonism-dementia complex of the Kii peninsula, Japan. Mov. Disord., 23, 2344-2348.
24. Funke, A.D., Esser, M., Kruttgen, A., Weis, J., Mitne-Neto, M., Lazar, M., Nishimura, A.L., Sperfeld, A.D., Trillenberg, P., Senderek, J. et al. (2010) The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin. Genet., 77, 302-303.
25. Millecamps, S., Salachas, F., Cazeneuve, C., Gordon, P., Bricka, B., Camuzat, A., Guillot-Noel, L., Russaouen, O., Bruneteau, G., Pradat, P.F. et al. (2010) SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J. Med. Genet., 47, 554-560.
26. Tsuda, H., Han, S.M., Yang, Y., Tong, C., Lin, Y.Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J. et al. (2008) The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell, 133, 963-977.
27. Pennetta, G., Hiesinger, P.R., Fabian-Fine, R., Meinertzhagen, I.A. and Bellen, H.J. (2002) Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron, 35, 291-306.
28. Chai, A., Withers, J., Koh, Y.H., Parry, K., Bao, H., Zhang, B., Budnik, V. and Pennetta, G. (2008) hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction. Hum. Mol. Genet., 17, 266-280.
29. Han, S.M., Tsuda, H., Yang, Y., Vibbert, J., Cottee, P., Lee, S.J., Winek, J., Haueter, C., Bellen, H.J. and Miller, M.A. (2012) Secreted VAPB/ ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev. Cell, 22, 348-362.
30. Kabashi, E., Lin, L., Tradewell, M.L., Dion, P.A., Bercier, V., Bourgouin, P., Rochefort, D., Bel Hadj, S., Durham, H.D., Vande Velde, C. et al. (2010) Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet., 19, 671-683.
31. Dupuis, L. and Loeffler, J.P. (2009) Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr. Opin. Pharmacol., 9, 341-346.
32. Gallarda, B.W., Bonanomi, D., Muller, D., Brown, A., Alaynick, W.A., Andrews, S.E., Lemke, G., Pfaff, S.L. and Marquardt, T. (2008) Segregation of axial motor and sensory pathways via heterotypic trans-axonal signaling. Science, 320, 233-236.
33. Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K.A., Laird, A.S., Peeters, E., Philips, T., Goris, A., Dubois, B. et al. (2012) EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat. Med., 18, 1418-1422.
34. van Blitterswijk, M., van Es, M.A., Hennekam, E.A., Dooijes, D., van Rheenen, W., Medic, J., Bourque, P.R., Schelhaas, H.J., van der Kooi, A.J., de Visser, M. et al. (2012) Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet., 21, 3776-3784.
35. Valdmanis, P.N. and Rouleau, G.A. (2008) Genetics of familial amyotrophic lateral sclerosis. Neurology, 70, 144-152.
36. Dupuis, L., Pradat, P.F., Ludolph, A.C. and Loeffler, J.P. (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol., 10, 75-82.
37. Labuda, D., Krajinovic, M., Richer, C., Skoll, A., Sinnett, H., Yotova, V. and Sinnett, D. (1999) Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. Anal. Biochem., 275, 84-92.
38. Bourgeois, S. and Labuda, D. (2004) Dynamic allele-specific oligonucleotide hybridization on solid support. Anal. Biochem., 324, 309-311.
39. Dentel, C., Palamiuc, L., Henriques, A., Lannes, B., Spreux-Varoquaux, O., Gutknecht, L., Rene, F., Echaniz-Laguna, A., Gonzalez De Aguilar, J.L., Lesch, K.P. et al. (2013) Degeneration of serotonin neurons in amyotrophic lateral sclerosis: a link to spasticity. Brain, 136 (Pt 2), 483-493.
40. Rogers, D.C., Fisher, E.M., Brown, S.D., Peters, J., Hunter, A.J. and Martin, J.E. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome, 8, 711-713.
41. Dupuis, L., Fergani, A., Braunstein, K.E., Eschbach, J., Holl, N., Rene, F., Gonzalez De Aguilar, J.L., Zoerner, B., Schwalenstocker, B., Ludolph, A.C. et al. (2009) Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. Exp. Neurol., 215, 146-152.
42. Dupuis, L., Gonzalez de Aguilar, J.L., Echaniz-Laguna, A., Eschbach, J., Rene, F., Oudart, H., Halter, B., Huze, C., Schaeffer, L., Bouillaud, F. et al. (2009) Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One, 4, e5390.
43. Eschbach, J., Fergani, A., Oudart, H., Robin, J.P., Rene, F., Gonzalez de Aguilar, J.L., Larmet, Y., Zoll, J., Hafezparast, M., Schwalenstocker, B. et al. (2011) Mutations in cytoplasmic dynein lead to a Huntington's disease-like defect in energy metabolism of brown and white adipose tissues. Biochim. Biophys. Acta, 1812, 59-69.
44. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, research0034.0031-0034.0011.